In a Law360 article, health care partners David Peloquin and Mark Barnes and associate Carmen Lam examined the Food and Drug Omnibus Reform Act, which includes several provisions intended to promote diversity in clinical trial enrollment, encourage the growth of decentralized clinical trials and streamline clinical trials. The authors note the guidance documents required by FDORA are likely to provide helpful clarity in several key areas for clinical trial sponsors, investigators, sites and institutional review boards.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.